top of page
MULTIDISCIPLINARY MASTERCLASS ON ADVANCED AND METASTATIC BREAST CANCER

Unique input of pathology, artificial intelligence and genetics for diagnostic and theranostic purposes

JUNE 29th 2023 - 14:30 - France time - Central European Summer Time (CEST)
speakers - 2023-02-01T122658.009.png
14:30-14:45
WELCOME
Dr Gérard Friedlander
University of Paris Foundation, France
speakers - 2023-02-01T115617.619.png
Dr ROBERT SIGAL
CEO American Hospital of Paris, France
speakers - 2023-02-01T123320.564.png
14:45-15:15
Dr marc Abehsera
American Hospital of Paris, France
Imaging work-up
speakers - 2023-02-01T155714.591.png
15:15-15:45
dr Patrick McIntire
Cleveland Clinic, Rochester, USA
Why test and/or re-test ER, PR, HER2
and PDL1 in tumors
speakers - 2023-02-01T160507.003.png
15:45-16:15
dr Emad A. Rakha
University of Nottingham & School of Medicine, Nottingham, United Kingdom
Update and issues of HER2-low detection by immunohistochemistry
speakers - 2023-02-01T161729.904.png
16:15-16:30
Q&A (Questions-and-Answers) Session

Moderator:
Dr Momin Siddiqui - Weill College of Medicine, New York, USA
speakers - 2023-02-01T164951.795.png
16:30-17:00
dr Salto-Tellez Manuel
Queen's University Belfast, Northern Ireland
Quantitative and therapeutic immunohistochemistry
using digital pathology
speakers - 2023-02-01T175636.872.png
17:00-17:30
IBEX
IBEX
TBD
speakers (17).png
17:30-18:00
dr Frederique Penault-Llorca
Jean Perrin Cancer Comprehensive Center, Clermont-Ferrand, France
Genomic alterations: a few "druggable"?
speakers - 2023-02-01T164651.108.png
18:00-18:15
Q&A (Questions-and-Answers) Session

Moderator:
Dr Philippe Vielh - Medipath / American Hospital of Paris, France
JUNE 30th 2023 - 14:30 - France time - Central European Summer Time (CEST)
speakers - 2023-02-01T165621.179.png
14:30-15:00
dr Mahasti Saghatchian
American Hospital of Paris, France
Treatment scenari of HER2 -/HR+ sensitive and resistant breast cancer
speakers (12).png
15:00-15:30
Paolo Tarantino
Dana Farber Cancer Institute, Boston, USA
Treatment scenari of HER2-amplified and HER2-low breast cancer
speakers - 2023-02-01T170354.528.png
15:30-16:00
dr Jean-Yves Pierga
Curie Institute, Paris, France
Treatment scenari of triple-negative breast cancer
speakers - 2023-02-01T164651.108.png
16:00:-16:15
Q&A (Questions-and-Answers) Session

Moderator:
Dr Philippe Vielh - Medipath / American Hospital of Paris, France
speakers - 2023-02-01T170702.019.png
16:15-16:45
dr Massimo Christofanilli
Weill Cornell Medicine, New York, USA
Liquid biopsy: circulating tumor cells
speakers - 2023-02-01T171037.160.png
16:45-17:15
dr Umberto Malapelle
Naples University, Naples, Italy
Liquid biopsy: circulating-tumor DNA
speakers - 2023-02-01T165621.179.png
17:15-17:45
Q&A (Questions-and-Answers) Session

Moderator:
Dr Mahasti SaghatchianAmerican Hospital of Paris, France 
bottom of page